Compare Abbott Laboratories (ABT) vs Alphabet Inc Class A (GOOGL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Alphabet Inc Class A — how do they compare? Abbott Laboratories trades at $94.9 (market cap $166.94B), while Alphabet Inc Class A trades at $361.37 (market cap $4.46T). The key difference: Alphabet Inc Class A is far larger — about 26.7× Abbott Laboratories's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | GOOGL | |
|---|---|---|
Market Cap | $166.94B | $4.46T |
Sector | Health | Media |
52-Week High | $136.62 | $402.62 |
52-Week Low | $82.57 | $174.36 |
Enterprise Value | $193.69B | $4.42T |
Dividend Yield | 2.63% | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Alphabet (GOOGL) trades at $361.92, down 1.24% on the day, amid a bullish technical setup with strong support at $357. The company reported robust Q1 2026 earnings of $5.11 EPS, beating estimates, and maintains high profitability with a 37.92% net income margin. Recent news highlights AI-driven growth opportunities, including partnerships and YouTube price increases.
Outlook remains positive with an 85% analyst buy rating and a $431.35 consensus price target, implying significant upside. Key risks include antitrust scrutiny and competitive pressures, but strong cash flow and earnings momentum support long-term growth for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Alphabet Inc Class A
Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.
Read more on GOOGL →
